reference/26487506

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26487506

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article
endingPage	e120
issn	2352-3026
issueIdentifier	2
pageRange	e111-e120
publicationName	The Lancet. Haematology
startingPage	e111
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e1c9cf2f5ce4b3cc596ea1c1793d0feb
bibliographicCitation	Admiraal R, Nierkens S, Bierings MB, Bredius RGM, van Vliet I, Jiang Y, Lopez-Yurda M, Versluijs AB, Zwaan CM, Lindemans CA, Boelens JJ. Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial. Lancet Haematol. 2022 Feb;9(2):e111–20. doi: 10.1016/s2352-3026(21)00375-6. PMID: 35114150.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e6cf72fdaac7def0f09adcbe9cffdf2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5408e470352d80255cf5542f0db3df7c http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3678-3222 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa76b11e2738ebbcfeab2a75ff2653e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb4e30748206f4b8a39bad5080cd4173 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ed8ec046f4f2f1a061b8a87e92c9943 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df649878319b8984a15ff2496d2ea564 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8ce450b11fc1389a22326d34df406bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0908c1268331efcff3adeca11dfebd4e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6c991bf3cdc51a5beaec0048545277b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd22172e0e6bdb94865a8b4c0fe7142d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a27946ffcbc47ae004210cd44fb41a5c
date	202202
identifier	https://doi.org/10.1016/s2352-3026%2821%2900375-6 https://pubmed.ncbi.nlm.nih.gov/35114150
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43133 https://portal.issn.org/resource/ISSN/2352-3026
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial
discusses	http://id.nlm.nih.gov/mesh/M0001464
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006086Q000209 http://id.nlm.nih.gov/mesh/D006086Q000517 http://id.nlm.nih.gov/mesh/D018380Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D009364 http://id.nlm.nih.gov/mesh/D019172 http://id.nlm.nih.gov/mesh/D000961Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002648
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7874 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167

Showing number of triples: 1 to 45 of 45.